A systematic approach to the development of a safe live attenuated Zika vaccine
A Zika virus (ZIKV) vaccine should provide long-lasting immunity, which may be achieved with a live-attenuated vaccine. Here, Kwek et al. select an interferon-restricted, attenuated ZIKV variant and evaluate replication and immunogenicity in mouse and mosquito models.
Main Authors: | Swee Sen Kwek, Satoru Watanabe, Kuan Rong Chan, Eugenia Z. Ong, Hwee Cheng Tan, Wy Ching Ng, Mien T. X. Nguyen, Esther S. Gan, Summer L. Zhang, Kitti W. K. Chan, Jun Hao Tan, October M. Sessions, Menchie Manuel, Julien Pompon, Camillus Chua, Sharifah Hazirah, Karl Tryggvason, Subhash G. Vasudevan, Eng Eong Ooi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-03337-2 |
Similar Items
-
Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection
by: Clement Yau, et al.
Published: (2020-11-01) -
Highly Efficient Vertical Transmission for Zika Virus in <i>Aedes aegypti</i> after Long Extrinsic Incubation Time
by: Menchie Manuel, et al.
Published: (2020-05-01) -
A Zika virus from America is more efficiently transmitted than an Asian virus by Aedes aegypti mosquitoes from Asia
by: Julien Pompon, et al.
Published: (2017-04-01) -
Production of Infectious Dengue Virus in Aedes aegypti Is Dependent on the Ubiquitin Proteasome Pathway.
by: Milly M Choy, et al.
Published: (2015-11-01) -
Host cell transcriptome profile during wild-type and attenuated dengue virus infection.
by: October M Sessions, et al.
Published: (2013-01-01)